Matthew Holt

The THCB Book Club! – The Health Care Blog – Health Article

Featured by JESSICA DAMASSA & MATTHEW HOLT We are launching a new THCB program! The THCB Book Club (TM) is going to be a discussion with leading health care authors, which will be released on the third Wednesday of every month. We are kicking off with the new book from Hemant Teneja (VC at General Catalyst who has been writing many big checks lately) and Stephen Klasko (CEO at Jefferson Health System and one of the most unusual hospital system bosses in…

Read More

Health in 2 Point 00, Episode 140 – Health Article

Health in 2 Point 00 Today on Health in 2 Point 00, Jess helps me celebrate my birthday Kylie Jenner-style. On Episode 140, Jess and I discuss Humana investing $100 million in Heal, Lemonaid raising $33 million in a Series B, CVS Caremark announcing 5 new companies in their digital health platform—4 of which are about weight loss, and perplexing health intelligence company Sema4 raising $121 million in a seed round. —Matthew Holt This is only a snippet of a…

Read More

Health in 2 Point 00, Episode 136 – Health Article

Health in 2 Point 00 On Episode 136 of Health in 2 Point 00, Jess has 15 new deals to talk about (and its only been a day since the last episode!). Jess asks me about CityBlock getting $54M for their Series B round to provide primary care services to dual-eligible Medicare and Medicaid members in New York, Medly raising $100M & NowRx crowdsourcing $20M to grow their telepharmacy platforms, the mega-merger of Curavi, Carepointe, and U.S. Health Systems (now…

Read More

THCB Spotlights: Carolyn Magill, CEO of Aetion – Health Article

Data Today on THCB Spotlights, Matthew interviews Carolyn Magill, CEO of Aetion. Aetion is a real world evidence analytics company working to accelerate time to regulatory grade insights. In fact, Aetion recently did a study with Horizon Blue Cross Blue Shield of New Jersey where they analyzed the type 2 diabetes population, identified a subset of patients who should be on a different class of drugs—which are more expensive—that would improve health outcomes and bring down the total cost of…

Read More

Health in 2 Point 00, Episode 103 | ACA Ruling, Sutter Health Settlement, & Bright Health – Health Article

Health in 2 Point 00 Today, I’m closing out the year of Health in 2 Point 00 from the ski slopes. In Episode 103, Jess asks me about the ACA ruling that the individual mandate is unconstitutional, whether Sutter Health got what they deserved after the $575 million settlement, health insurer Bright Health raising a huge $635 million round, and a rumor about a $250M Softbank investment coming next week. Wishing you all a very happy 2020! —Matthew Holt Related…

Read More

Health in 2 Point 00, Episode 102 | Proteus, Health 2.0 Asia/Japan, and…a Jewel Heist? – Health Article

Health 2.0 Today on Health in 2 Point 00, Jess is in Las Vegas while I’m all the way in Tokyo for Health 2.0 Japan. In Episode 102, Proteus Digital (finally) announces that they’re running out of money. Does this put the whole category of digital therapeutics at risk? In other news, Seema Verma’s jewelry was stolen and she wants taxpayers to pay her back! How is she going to survive this? And find out what’s going on in Tokyo…

Read More

THCB Spotlights: Todd Clardy, EVP Marketing at Accolade – Health Article

Health Tech Today on THCB Spotlights, Matthew interviews Todd Clardy who is the EVP of Marketing at Accolade. Accolade is a company well-known for being in employee/patient advocacy. They’ve created an advocacy model that focuses on creating an outstanding member experience and supporting patients through their whole journey, whether it’s an acute or chronic condition or helping people maintain their health and wellness. Where do Amazon, Google and Haven fit into this space? Find out how many people have got…

Read More